Processing Magazine

Study: Ibuprofen may increase risks of kidney cancer

September 14, 2011
BOSTON — A recently published study in Archives of Internal Medicine indicates that people who regularly used ibuprofen were 51 percent more likely to develop kidney cancer than those who didn’t take the pain medicine, Bloomberg reported.

According to the study, there was not an increased risk from aspirin or acetaminophen.

The findings run counter to earlier studies that suggested ibuprofen and naproxen could reduce the risk of more common tumors, including breast, prostate and colon cancer.

“It’s something people need to keep in mind, that this may increase the risk of certain cancers,” said lead researcher Eunyoung Cho, an epidemiologist at Brigham and Women’s Hospital in Boston. “If our study is confirmed, the risks and benefits should be considered in trying to decide whether to use analgesics, especially for long durations.”